An intact microbiota is required for the gastrointestinal toxicity of the immunosuppressant mycophenolate mofetil

An intact intestinal microbiota is required to initiate and sustain the GI toxicity of MMF. MMF treatment causes dynamic changes in the composition of the intestinal microbiota that may be a targetable driver of the GI side-effects of MMF.